The increase in antibiotic resistance in Gram-negative bacteria and the limited therapeutic options due to the shortage of new antibiotics have increased the interest of the 'old' antibiotic fosfomycin in the treatment of infections. However, there are contradictory reports on the pharmacodynamics of and emergence of resistance to fosfomycin.
Introduction
The increase in antibiotic resistance in Gram-negative bacteria and the limited therapeutic options due to the shortage of new antibiotics has increased the interest of the 'old' antibiotic fosfomycin in the treatment of serious infections. Fosfomycin is a phosphonic acid derivative that was discovered almost 50 years ago from various strains of Streptomyces spp. with activity against a wide range of Gram-negative pathogens and some Gram-positive pathogens. 1 Fosfomycin has shown to have good bactericidal in vitro activity against Gram-negative, e.g. Pseudomonas aeruginosa, as well as Gram-positive species, e.g. Staphylococcus aureus, Staphylococcus epidermidis and the Enterobacteriaceae. The latter include ESBL-as well as carbapenemase-producing strains such as Escherichia coli, Klebsiella pneumoniae and Enterobacter cloacae. 2, 3 In Europe, fosfomycin is available as two oral formulations, namely fosfomycin trometamol a derivative of fosfomycin and fosfomycin calcium both used to treat uncomplicated urinary tract infections primarily caused by E. coli. [4] [5] [6] High concentrations of unchanged fosfomycin are achieved for a long period in urine after a single oral dose 3 g of fosfomycin trometamol. In addition relevant concentrations have been found in serum and other tissues such as the interstitial fluid of muscle, infected lung tissue, abscess fluid, heart valves, prostate and cerebral spinal fluid. 7 The intravenous formulation, fosfomycin disodium, is mainly used in combination with other antibiotics to treat systemic infections caused by MDR organisms, e.g. carbapenem-resistant K. pneumoniae and MRSA. [8] [9] [10] V C The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Despite its long use, the pharmacodynamic properties of fosfomycin are not well described. In a few limited studies both concentration-dependent and time-dependent killing have been observed in vitro.
11 Time-dependent killing similar to the b-lactam type of killing was observed for staphylococci, enterococci and Pseudomonas. 3, [12] [13] [14] [15] In contrast, limited concentrationdependent killing was reported for both E. coli and Proteus mirablis. 4 Finally, it was suggested that, because of observed concentration-dependent killing of Streptococcus pneumoniae, C max /MIC would be the best predictor of fosfomycin efficacy similar to the aminoglycosides. 16 One of the reasons for these conflicting reports may be fast regrowth after exposure or fast emergence of resistance. It is not always clear whether this is due to true resistance or a phenotypical phenomenon, although the former has been described. 17 Alternatively, in susceptibility testing (micro)colonies appear within the inhibition disc zone that can be neglected and, and using the agar dilution method up to two colonies can be ignored while interpreting the MIC value, but indicate the presence of a resistant subcolonies. 18 Given these conflicting reports on the pharmacodynamic behaviour of fosfomycin and emergence of resistance, we assessed the pharmacodynamics of fosfomycin in a collection of Enterobacteriaceae using extensive time-kill assays, including analysis of subpopulations.
Materials and methods

Bacterial strains
Eleven ESBL-or carbapenemase/metallo-b-lactamase-producing clinical strains [E. coli (n " 3), K. pneumoniae (n " 4), E. cloacae (n " 3) and C. freundii (n " 1)] and three ESBL-negative strains [E. coli (n " 2) and E. cloacae (n " 1)] with known genotypes were included in the study. Characteristics of the strains are shown in Table 1 . The clinical isolates originated from the Netherlands (O) or Greece (L and A). 19 The majority of the strains harboured CTX-M-type b-lactamases together with other resistance genes (OXA, SHV and TEM). Two strains harboured KPC-and VIM-type carbapenemases.
Antibiotics
Fosfomycin disodium salt (CAS 26016-99-9) was obtained from Molekula (Munich, Germany) and D-glucose-6-phosphate disodium salt hydrate (G6P) (CAS 3671-99-6) from Roche (Mannheim, Germany). The potency of the fosfomycin and G6P was derived from the certificate of analysis. Water was the solvent for preparing stock solutions following ISO recommendations. 20 All stock solutions were stored at #80 C; prior to each experiment, an aliquot was thawed to prepare the required concentrations.
Susceptibility testing
The MICs were determined in triplicate or quadruplicate on different days by the agar dilution method according to ISO guidelines. 20 In brief, Mueller-Hinton II agar (BD Bioscience, Erembodegem, Belgium) supplemented with 25 mg/L G6P with fosfomycin concentrations ranging from 0.062 to 1024 mg/L were poured and inoculated on the surface with 10 lL of 1%10 6 cfu/mL and incubated for 18 h at 37 C. E. coli ATCC 25922, Enterococcus faecalis ATCC 29212, P. aeruginosa ATCC 27853 and S. aureus ATCC 29213 were used as quality control strains.
Time-kill assays
Glass bottles of 20 mL of CAMHB supplemented with 25 mg/L G6P containing 2-fold increasing static concentrations of fosfomycin (from 0.125% to 32% the MIC) were prepared and inoculated with 200 lL of a 0.5 McFarland bacterial suspension to reach a final concentration of 1%10 6 cfu/mL. The bottles were incubated in darkness at 37 C under shaking conditions (260 rpm) for 24 h. A growth control bottle, with inoculum but without antibiotic, as well as a sterility control (medium only) was included.
To assess the effect of fosfomycin on bacterial growth, 20 lL samples were taken from each bottle at selected time intervals (0, 1, 2, 3, 4, 6, 8, 16 and 24 h after the start of the experiment) and serial 10-fold dilutions in 0.9% saline solution in 96-well plates were prepared. Ten lL from each dilution and an undiluted sample were plated in triplicate on Mueller-Hinton agar plates (BD Bioscience). The numbers of cfu were counted after incubation for 20-24 h at 37 C. The lower limit of detection (LOD) was 33.3 cfu/mL per plate corresponding to 1.52 log 10 cfu/mL.
Emergence of resistance
Emergence of resistance to fosfomycin was assessed during the time-kill assay before drug exposure (time 0) and at 8, 16 and 24 h at concentrations with no selective pressure (controls), very low (0.25% MIC), low (2% MIC) and high selective pressure (16% MIC). Undiluted (200 lL) and serial 10-fold dilutions (100 lL) from 0%, 0.25%, 2% and 16% MIC bottles were plated on agar plates containing no fosfomycin or containing antibiotic at 16% MIC to quantify the fosfomycin-resistant subpopulation and resistance proportion. All plates were supplemented with 25 mg/L G6P. The LOD was 5 cfu/mL corresponding to 0.70 log 10 cfu/mL. To verify whether the colonies that grew on antibiotic-containing plates had an elevated MIC, several colonies were selected from each plate and the MICs determined using agar dilution as described above. To verify if the colonies had permanently elevated MICs, the colonies were suspended in fresh CAMHB without antibiotic and after 24 h of incubation transferred to another fresh CAMHB tube and incubated again. In total, three transfer steps were performed (3 days 24 h growth). After 72 h a small sample was plated on to a blood agar plate. The next day several colonies were selected and the MICs determined as described above.
Pharmacodynamic analysis
The data derived from the time-kill assays were analysed using GraphPad Prism 6.0 (GraphPad, San Diego, CA, USA). Bacterial counts (log 10 cfu/mL) were plotted against time for each strain. The kill rate (log 10 cfu/mL % h #1 ) 
In vitro pharmacodynamics of fosfomycin JAC was determined for the time interval of 0-6 h by linear regression analysis, followed by plotting log 10 -transformed concentrations to slope. The sigmoid maximum effect (E max ) model (four-parameter Hill equation) was fitted to the kill rate data, analysing each time-kill assay to determine the pharmacodynamic relationship between antibiotic concentration and bacterial growth or death. 21, 22 For comparison between strains and species parameters were normalized by MIC analogous to pharmacodynamic index calculations: the maximal kill rate (E max ), 50% effective concentration normalized by the MIC (EC 50 /MIC), the concentration corresponding to stasis, no cfu reduction compared with initial inoculum (stasis) and stasis normalized by the MIC (C stasis /MIC), Hill slope (Ç) and R 2 were calculated for each time-kill assay. Differences in mean pharmacodynamic parameters were assessed with analysis of variance (ANOVA). C. freundii was excluded from the statistical analysis, because only one strain was tested and therefore ANOVA was not possible. Bactericidal effects (3 log 10 cfu/mL reduction from initial inocula) and regrowth (increased growth after an initial cfu reduction) was assessed by visual inspection of time-kill curves for each strain and concentration.
Results
Susceptibility
The MICs (mode, range) determined for fosfomycin together with the resistance phenotypes for each strain are shown in Table 1 . Twelve strains were susceptible to fosfomycin according to EUCAST criteria and two were resistant to fosfomycin. 18 The fosfomycin MIC ranges for E. coli strains were 0.5-2 mg/L, 8-32 mg/L for K. pneumoniae, 1 mg/L for C. freundii and 2-64 mg/L for E. cloacae. Figure 1 show the patterns of growth and kill by fosfomycin for examples of E. coli, K. pneumoniae, E. cloacae and C. freundii, respectively, at different concentrations of fosfomycin. After initially fast killing the bactericidal effect only lasted for a short period and regrowth started to occur from 4 to 6 h onwards and was observed for almost all strains at almost all concentrations.
Time-kill assays
The growth rates in the drug-free control as determined over the first 6 h were quite similar for E. coli and K. pneumoniae (0.56-0.57 log 10 cfu/mL % h #1 ) with only small strain differences. Those for E. cloacae and C. freundii were slightly lower at 0.51 and 0.44 log 10 cfu/mL % h #1 , respectively. The maximum growth was observed within 8-16 h for all strains and was similar for all species, 1.0-1.5%10
9 cfu/mL (data not shown). When E. coli strains were exposed to fosfomycin a large variety in response was observed, even if normalized for the MIC. For two strains O5 and O39 a bactericidal effect (3 log 10 cfu/mL reduction) was only observed at the highest tested concentration (32% MIC) at 6 h. For the other strains fosfomycin appeared to be also effective at lower multiples of the MIC and at earlier timepoints. In E. coli Fransen et al.
strain O51 a bactericidal effect was observed at 0.5% MIC within 1-3 h, while a bactericidal effect for ATCC 25922 and O41 at 2 and 4% MIC, respectively, was observed within 3-4 h. Fosfomycin was bactericidal against most K. pneumoniae within 3-6 h at a concentration of 8-32% MIC. For strain O6 bactericidality occurred much later and only at 32% MIC. In most experiments with E. cloacae and C. freundii, fosfomycin was bactericidal within 2-4 h at a concentration of 2% MIC.
Emergence of fosfomycin resistance
At baseline, resistant subpopulations were detected in more than half of the number of strains (8 of 14). They were detected on plates that contained fosfomycin at a concentration of 16% MIC, with a mean resistance proportion between the resistant subpopulation and total population of 4-7%10
#6
. In 6 of 14 strains no resistant subpopulations were detected (E. coli O51 and ATCC 25922, K. pneumoniae O20, E. cloacae O21 and O94 and C. freundii O26), indicating that resistant subpopulations were absent or that their number was below the detection limit. Another explanation might be that their MIC was only 5% increased and were therefore not able to grow on a plate that contained a concentration of 16% MIC. Figure 2 shows examples of changes in the total and fosfomycin-resistant subpopulations over time. After 8 h of exposure to fosfomycin there appeared to be a rapid emergence of resistance in bacteria exposed to fosfomycin concentrations at both low and high selective pressure concentrations (2% MIC). The figure further shows the difference between low and high selective pressure. At the highest concentrations (16% MIC), fosfomycinresistant subpopulations have replaced the total population almost completely at 24 h. This is further demonstrated in Figure 3 , showing the emergence of resistant subpopulations for all strains. For the three different timepoints (8, 16 and 24 h of exposure), the figure shows the resistance proportion as the ratio between the resistant subpopulation and total population for each strain, at various degrees of selective pressure (0-16% MIC). After 24 h, in the fosfomycin-exposed cultures (2% and 16% MIC) the median ratios between the resistant and total population increased tremendously with increasing selective pressure concentrations as compared with 0 h. The resistance proportion increased from 2%10 #6 to 0.652 (2% MIC) and 0.899 (16% MIC). However, the range in proportions was very broad over all strains. For three of four E. cloacae strains and the C. freundii strain the proportions did not increase above 0.01 at 2% MIC.
In all controls the median (range) resistance proportion was still very low [1.3%10 #7 (5%10 #7 -3.6%10
#5
)] as well as for the majority of strains (12 of 14) exposed to 0.25% MIC. This indicates that only a very small part of the population was/became resistant when exposed to very low levels of fosfomycin. Two exceptions were observed, however, namely one K. pneumoniae (O6; 0.428) and E. coli (O5; 0.05), that had increased proportions even at a very low selective pressure concentration.
Confirmation of the MIC of the strains that were able to grow on antibiotic-containing plates indicated that the MICs for all 14 strains were always strongly elevated indicating true resistance. Moreover, after three transfer steps, i.e. 3 days % 24 h growth in fresh CAMHB without fosfomycin, the MICs remained high, indicating stable resistance. For example, the MIC value for K. pneumoniae O6 increased from 16 to 1024 mg/L and E. coli O5 increased from 0.5 to 128 mg/L, and after passage showed similar MICs (results not shown). In vitro pharmacodynamics of fosfomycin JAC Time-kill modelling Figure 4 shows the relationship between kill rate and concentration for each strain. Pharmacodynamic parameter estimates E max , Hill slope, EC 50 /MIC, stasis and C stasis /MIC were obtained with the E max model with variable slope and are displayed in Table 2 . Overall the E max model fitted well to the concentration-kill rate data with R 2 . 0.95 for 13 of 14 strains. Using the E max model no significant differences in mean maximum kill rates between species were observed (P " 0.4170). Only for E. cloacae it was somewhat higher (0.66 versus 0.54-0.56 h
#1
), but overall there appeared to be more variation within species than between species.
On average 20-25% lower concentrations were required for E. coli strains to reach stasis as compared with the other species (P " 0.067), with the exception of non-ESBL E. cloacae strain O94 Fransen et al.
which required similar concentrations. Because of the large variation in determined MIC values the concentration to reach either a 50% effect or stasis was normalized by MIC (EC 50 /MIC) for better comparison of the results. The differences between species for the EC 50 /MIC (0.29-0.44) and C stasis /MIC (0.27-0.46) were both small and non-significant. The difference in mean Hill slope factors between species was not considered significant (P " 0.1400). However, a rather broad range was observed for E. coli, which was not the case for K. pneumoniae and E. cloacae. This indicated that within one species, i.e. E. coli, the type of killing can be concentration as well as time dependent.
Discussion
This study presents basic pharmacodynamic information for fosfomycin used to treat infections caused by Enterobacteriaceae. Bactericidal effects were observed for all species studied. However, resistance amplification occurred fast.
Currently the pharmacokinetic/pharmacodynamic index associated with microbiological activity of fosfomycin is still not clear and both concentration-and time-dependent activity have been suggested. 11 We here observed that, although the bactericidal killing response to fosfomycin was relatively fast, in particular at higher concentrations, there was significant variability. This was particularly so for E. coli and appeared to be more time dependent (shallower S-curves) for three strains and concentration dependent for two other strains. For both E. cloacae and K. pneumoniae the killing behaviour appeared to be relatively concentration dependent (slope factors 1.0). These findings indicate that efficacy of fosfomycin might be more related to AUC for some strains, and more time dependent for others. The murine model of Lepak et al., 23 demonstrated that AUC/MIC was the pharmacokinetic/ pharmacodynamic index most closely linked to efficacy. In our earlier study with nitrofurantoin, we observed clear interspecies differences with respect to pharmacodynamic behaviour. 24 Here, the conclusion could be taken one step further, in that there are even intra-species differences. These observations and conclusions clearly need validation in in vivo experiments. However, they do explain the different conclusions with respect to time dependence and concentration dependence found by other investigators, as they mostly studied limited numbers of strains only. 3, 4, [12] [13] [14] [15] [16] In our study, rapid emergence of resistance occurred already after 8 h of in vitro exposure to a wide range of Enterobacteriaceae with variable MICs (very sensitive resistant). This is much earlier than observed for by Docobo-Pérez et al. 25 In those experiments emergence of resistance was observed in susceptible ESBLproducing E. coli (1 mg/L) only after 48 h. However, in agreement with our findings their resistant ESBL E. coli (64 mg/L) also developed resistance within 8 h. 25 In the study of Albur et al. 26 there was no growth on 2% or 4% MIC plates at 24 h in either fosfomycinsusceptible or -resistant strains. At 48 h there was growth observed on 2% and 4% MIC plates for the susceptible strains. Only after 5 days resistant subpopulations were observed for the fosfomycin strains that initially were low-level resistant. 26 Finally, in the in vitro model of Corvec et al. 27 resistance to fosfomycin did not occur at all in the ESBL-producing E. coli strain on 4% MIC plates.
As we did not include E. coli strains with MIC values above the EUCAST breakpoints, we can only speculate about the effects for E. coli with those higher MIC values. On the other hand, the Enterobacter and Klebsiella strains that we included here and called resistant based on the MIC, probably belonged to the WT distribution of these species. No epidemiological cut-off values are defined for these two species, but the distributions appear to extend beyond 32 mg/L. 28 For all the Enterobacteriaceae tested, emergence of resistance occurred extremely fast and the extent of growth of resistant In vitro pharmacodynamics of fosfomycin JAC mutants reached drug-free control levels. Emergence of resistance already occurred when strains were exposed to relatively low concentrations of fosfomycin (0.25% MIC), indicating that very low concentrations already of fosfomycin might trigger the development or amplification of resistance in some strains independently from the MIC value. However, for each time-kill curve the starting inoculum is critical to detect resistant subpopulations. A starting inoculum of 1%10 6 cfu/mL was chosen to allow adequate measurements of both growth and kill.
There are several limitations of this study. Although we clearly demonstrated emergence of resistant subpopulations after initial exposures and bactericidal effects, we did not perform a full population analysis. We choose to culture on plates with 16% MIC only to detect potential subpopulations. Thus, we may have missed some mutant colonies with increased MICs that would be able to grow on plates containing a concentration ,16% MIC (e.g. 4% MIC). However, this does not impact our overall conclusions. Furthermore, the three resistance mechanisms described to occur most frequently are decreased drug uptake (mutations in GlpT and/or UhpT transport systems), modification of MurA, target of fosfomycin and inactivation of fosfomycin by the presence of enzymes FosA, FosB or FosX all result in strongly elevated MICs. 17 Thus, most of the resistant strains will have been captured using the 16% MIC-selective plates. However, very recently a relationship was found between fosfomycin-resistant mutations that triggered the mutant frequency but did not have an impact on the MIC value. 29 Thus, although present, they may not be detected in standard tests. This may have potential implications for routine testing. Another limitation is that we did not molecularly characterize the strains that appeared resistant on the selective plates. This was not the purpose of this study. However, we did validate whether the strains were resistant using repeated MIC testing of selected colonies, and none of these appeared to be susceptible on retesting-thus, although the exact mechanism is not known, and is currently under study, resistance appeared to be real. Moreover, we used a serial passage of 3 days and acquired resistance appeared to be stable as well-in all cases elevated MICs could be confirmed.
In conclusion, fosfomycin was bactericidal against all strains within 8 h. However, emergence of resistance was observed after 8 h for all strains with growth reaching drug-free control levels. This may potentially limit the use of fosfomycin as a single drug therapy in serious infections. Further optimization of fosfomycin pharmacodynamics and pharmacokinetics is required using in vitro pharmacodynamic models and/or animal models are required to increase efficacy against ESBL-positive pathogens.
